-+ 0.00%
-+ 0.00%
-+ 0.00%
A Look At Boston Properties (BXP) Valuation After Q1 2026 Beat And Raised Guidance
Share
Listen to the news

Boston Properties (BXP) surprised the market with Q1 2026 results that topped its own guidance, as higher net income, better portfolio occupancy and leasing, and raised EPS and FFO guidance drew fresh analyst attention.

See our latest analysis for BXP.

Despite the earnings beat and raised guidance, BXP’s recent share price performance has been mixed, with a 4.43% 1 month share price return but a year to date share price decline of 11.10%. The 3 year total shareholder return of 45.59% contrasts with a weaker 5 year total shareholder return, suggesting longer term momentum has softened.

If this kind of mixed performance has you comparing alternatives, it could be a good moment to broaden your search and check out 20 top founder-led companies

With BXP trading at US$60.29 and sitting at an estimated 28.30% discount to one intrinsic value estimate and a 13.87% discount to analyst targets, you have to ask: is this a genuine opportunity, or is the market already pricing in the future growth story?

Most Popular Narrative: 13% Undervalued

The most followed narrative pegs BXP's fair value at $69.30, above the last close at $60.29, and builds that gap around premium gateway assets and development returns.

BXP's aggressive capital recycling and asset sales strategy (targeting $600 million in non-core dispositions), along with redevelopment and adaptive reuse of assets for mixed-use and multifamily, is expected to unlock higher-yielding income streams, fortify net margins, and provide non-dilutive funding for growth, supporting future FFO and earnings resilience.

Read the complete narrative.

Want to see what is baked into that valuation gap? Revenue growth, profit margins and a rich future earnings multiple all sit at the core. The narrative leans on detailed forecasts, not headlines, to reach its fair value.

Result: Fair Value of $69.30 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story can change quickly if occupancy remains under pressure or if life science and technology leasing stays subdued, keeping vacancy elevated for longer.

Find out about the key risks to this BXP narrative.

Next Steps

Mixed messages on valuation and fundamentals can be hard to weigh, so move quickly, review the data for yourself, and weigh up the 3 key rewards and 4 important warning signs.

Looking for more investment ideas?

If BXP has your attention but you want a wider view, now is the moment to scan other opportunities before the next round of results reshapes the field.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending